Improving the presumptive disability decision-making process for veterans

Improving the Presumptive Disability Decision-Making Process for Veterans

Volumn , Issue , 2008, Pages 1-813

  Samet, Jonathan M ^a   Bodurow, Catherine C ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84991041599     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.17226/11908     Document Type: Book

References (445)

1. IOM (Institute of Medicine). 1994. Veterans and Agent Orange: Health effects of herbicides used in Vietnam. Washington, DC: National Academy Press.
2. IOM. 1996. Veterans and Agent Orange: Update 199 6. Washington, DC: National Academy Press.
3. IOM. 1999. Veterans and Agent Orange: Update 1998. Washington, DC: National Academy Press.
4. IOM. 2000. Gulf War and health, volume 1: Depleted uranium, pyridostigmine bromide, sarin, vaccines. Washington, DC: National Academy Press.
5. IOM. 2000. Veterans and Agent Orange: Herbicide/dioxin exposure and type 2 diabetes. Washington, DC: National Academy Press.
6. IOM. 2001. Veterans and Agent Orange: Update 2000. Washington, DC: National Academy Press.
7. IOM. 2003. Gulf War and health, volume 2: Insecticides and solvents. Washington, DC: The National Academies Press.
8. IOM. 2003. Veterans and Agent Orange: Update 2002. Washington, DC: The National Academies Press.
9. IOM. 2005. Gulf War and health, volume 3: Fuels, combustion products, propellants. Washington, DC: The National Academies Press.
10. IOM. 2005. Veterans and Agent Orange: Update 2004. Washington, DC: The National Academies Press.
11. IOM. 2006. Gulf War and health, volume 4: Health effects of serving in the Gulf War. Washington, DC: The National Academies Press.
12. IOM. 2007. Gulf War and health, volume 5: Infectious diseases. Washington, DC: The National Academies Press.
13. Pamperin, T. J. 2006. An overview of the Disability Benefits Program and presumptions affecting veterans' benefits. Paper presented at the first meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans, Washington, DC.
14. VBA (Veterans Benefits Administration). 2006. Annual benefits report fiscal year 2005. http:// www.vba.va.gov/bln/dmo/reports/fy2005/2005_abr.pdf (accessed February 26, 2007).
15. VDBC (Veterans Disability Benefits Commission). 2006. Statement of the Veterans' Disability Benefits Commission to the IOM's Committee on Presumptive Disability Decision- Making Process. Washington, DC: VDBC.
16. Zeglin, D. E. 2006. Presumptions of service connection. Paper prepared for the Veterans' Disability Benefits Commission. https://www.1888932-2946.ws/vetscommission/ e-documentmanager/gallery/Documents/Reference:Materials/Presumption-Paper_3-7- 06.pdf (accessed March 8, 2007).
17. Dunne, P. W. 2006. Department of Veterans Affairs responses: Questions following from the Veteran's Disability Benefits Commission's charge. Letter to Jonathan M. Samet.
18. Grady, J. 2006. Statement presented at the first committee meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans. Washington, DC.
19. Mansfield, G. H. 2006. Internal VA process for reviewing reports on the Institute of Medicine under the Agent Orange Act of 199 1 and the Persian Gulf War Veterans Act of 1998. Letter to Susanne A. Stoiber.
20. VA (Department of Veterans Affairs). 1996. Diseases associated with exposure to certain herbicide agents. Proposed Rule. Federal Register 61(154):41368-41371.
21. VA. 2006. Department of Veterans Affairs responses: Questions following from the Veteran's Disability Benefits Commission's charge. Washington, DC: Department of Veterans Affairs.
22. VDBC (Veterans Disability Benefits Commission). 2006. Statement of the Veterans' Disability Benefits Commission to the IOM's Committee on Presumptive Disability Decision Making Process. Washington, DC.
23. Allen, R. 1980. Presumptions in civil actions reconsidered. Iowa Law Review 66:843-867.
24. Barrans, D. 2006. History of presumptions of service connection. Paper presented to the Institute of Medicine's Committee on Evaluation of the Presumptive Disability Decision- Making Process for Veterans, Washington, DC.
25. Economic Systems Inc. 2004. VA Disability Compensation Program: Legislative history. Washington, DC: VA Office of Policy, Planning and Preparedness.
26. Economic Systems Inc. 2004. VA Disability Compensation Program: Literature review. Washington, DC: VA Office of Policy, Planning and Preparedness.
27. Pamperin, T. J. 2006. An overview of the Disability Benefits Program and presumptions affecting veterans' benefits. Presented to the Institute of Medicine's Committee on Evaluation of the Presumptive Disability Decision-Making Process for Veterans, Washington, DC.
28. President's Commission on Veterans' Pensions. 1956. A report to the president: Veterans benefits in the United States: Findings and recommendations. Vol. 1, Parts I and II. Washington, DC: Government Printing Office.
29. Reagan, R. 1988. Statement on signing the Radiation-Exposed Veterans Compensation Act of 1988. Weekly Compilation of Presidential Documents 24(20):641-642.
30. VA (Veterans Administration). 1921. Internal memorandum implementing Veteran's Bureau Regulation No. 11. Washington, DC: VA.
31. VA. 1925. Schedule for rating disabilities. Washington, DC: VA. P. 75.
32. VA. 1928. Schedule of disability ratings. Extension 6. Washington, DC: VA.
33. VA. 1945. Veterans Administration Circular No. 8. Section I. Washington, DC: VA.
34. VA. 1947. Disability ratings for malaria and chronic diseases characteristically tropical in origin. Veterans Administration Technical Bulletin 8-6. Washington, DC: VA.
35. VA. 1949. Pensions, bonuses, veterans' relief: Veterans' claims; miscellaneous amendments. Part 3. Federal Register 14(26):568-578.
36. VA. 1949. Pensions, bonuses, veterans' relief: Veterans' claims; miscellaneous amendments. Part 3. Federal Register 14(197):6174-6180.
37. VA. 1950. Pensions, bonuses, veterans' relief: Veterans' claims; miscellaneous amendments. Part 3. Federal Register 15(169):5902-5910.
38. VA. 1961. Disease subject to presumptive service connection. Federal Register 26(36):1581-1582.
39. VA. 1970. Pensions, bonuses, veterans' relief. Part 3: Adjudication. Subpart A: Pension, compensation, dependency and indemnity compensation. Federal Register 35(232):18280-18283.
40. VA. 1979. Pension, compensation, dependency and indemnity compensation, proximate results, secondary conditions. Federal Register 44(168):50339-50340.
41. VA. 1985. Adjudication of claims based on exposure to dioxin or ionizing radiation. Final rules. Federal Register 50(165):34452-34461.
42. VA. 1990. Claims based on service in Vietnam. Final regulations. Federal Register 55(208):43123-43125.
43. VA. 1992. Claims based on chronic effects of exposure to mustard gas. Final rule. Federal Register 57(148):33875-33877.
44. VA. 1992. Claims based on exposure to herbicides containing dioxin (peripheral neuropathy/ lung cancer). Proposed rule. Federal Register 57(13):2236-2238.
45. VA. 1993. Analysis of presumptions of service connection. Washington, DC: VA.
46. VA. 1993. Claims based on exposure to ionizing radiation. Final rule. Federal Register 58(57):16358-16359.
47. VA. 1993. Direct service connection (post-traumatic stress disorder). Final rule. Federal Register 58(95):29109-29110.
48. VA. 1993. Diseases associated with service in the Republic of Vietnam. Final rule. Federal Register 58(95):29107-29109.
49. VA. 1994. Claims based on chronic effects of exposure to mustard gas or lewisite. Final rule. Federal Register 59(159):42497-42500.
50. VA. 1994. Claims based on exposure to ionizing radiation. Final rule. Federal Register 59(171):45975.
51. VA. 1994. Compensation for certain undiagnosed illnesses. Proposed rule. Federal Register 59(235):63283-63285.
52. VA. 1994. Disease associated with exposure to certain herbicide agents. Final rule. Federal Register 59(23):5106-5107.
53. VA. 1994. Disease associated with exposure to certain herbicide agents (multiple myeloma and respiratory cancers). Final rule. Federal Register 59(110):29723-29724.
54. VA. 1995. Claims based on exposure to ionizing radiation (lymphomas other than Hodgkin's disease and cancer of the rectum). Final rule. Federal Register 60(198):53276-53277.
55. VA. 1995. Compensation for certain undiagnosed illnesses. Final rule. Federal Register 60(23):6660-6666.
56. VA. 1996. Diseases associated with exposure to certain herbicide agents (prostate cancer and acute and subacute peripheral neuropathy). Final rule. Federal Register 61(217):57586-57589.
57. VA. 1997. Compensation for certain undiagnosed illnesses. Interim rule with request for comments. Federal Register 62(82):23138-23139.
58. VA. 1998. Claims based on exposure to ionizing radiation (prostate cancer and any other cancer). Final rule. Federal Register 63(185):50993-50995.
59. VA. 2000. Veterans Millennium Health Care and Benefits Act. Final rule. Federal Register 65(136):43699-43700.
60. VA. 2001. Claims based on the effects of tobacco products. Final rule. Federal Register 66(67):18195-18198.
61. VA. 2001. Disease associated with exposure to certain herbicide agents: Type 2 diabetes. Final rule. Federal Register 66(89):23166-23169.
62. VA. 2001. Diseases specific to radiation-exposed veterans. Proposed rule. Federal Register 66(153):41483-41485.
63. VA. 2001. Extension of the presumptive period for compensation for Gulf War veterans' undiagnosed illnesses. Interim final rule with request for comments. Federal Register 66(218):56614-56615.
64. VA. 2002. Diseases specific to radiation-exposed veterans. Final rule. Federal Register 67(17):3612-3616.
65. VA. 2003. Disease associated with exposure to certain herbicide agents: Chronic lymphocytic leukemia. Final rule. Federal Register 68(200):59540-59542.
66. VA. 2003. Presumption of service connection for cirrhosis of the liver in former prisoners of war. Final rule. Federal Register 68(138):42602-42603.
67. VA. 2004. Presumptions of service connection for diseases associated with service involving detention or internment as a prisoner of war. Interim final rule. Federal Register 69(194):60083-60090.
68. VA. 2005. Presumptions of service connection for diseases associated with service involving detention or internment as a prisoner of war. Affirmation of interim final rule as final rule. Federal Register 70(123):37040-37042.
69. VA. 2006. Extension of the presumptive period for compensation for Gulf War veterans. Interim final rule. Federal Register 7(242):75669-75672.
70. VA. 2006. Presumption of service connection: The public policy debate. Washington, DC: VA.
71. VA. 2006. Presumptions of service connection. Washington, DC: VA.
72. Zeglin, D. E. 2006. Presumptions of service connection. Paper prepared for the Veterans' Disability Benefits Commission. https://www.1888932-2946.ws/vetscommission/ e-documentmanager/gallery/Documents/Reference:Materials/Presumption-Paper_3-7- 06.pdf (accessed March 8, 2007).
73. Barrans, D. 2006. History of presumptions of service connection. Paper presented at the first meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision- Making Process for Veterans, Washington, DC.
74. Brown, M. 2006. The role of science in Department of Veterans Affairs disability compensation policies for environmental and occupational illness and injuries. Paper presented at the first meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans, Washington, DC.
75. Carr, T. P. 2001. CRS report for Congress. Parliamentary reference sources: House of Representatives. CRS report RL30787. Washington, DC: Congressional Research Service. http://lugar.senate.gov/CRS%20reports/Parliamentary_Reference:Sources_House. pdf (accessed April 30, 2007).
76. Cranston, A. 1990. Agent Orange update. Senate Congressional Record 101st Cong., 2nd Sess. November 2. Presented by Scott, E. P., at the third meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans, San Antonio, TX.
77. Deyton, L. 2006. Introduction to VA health care system and assessing environmental/occupational exposures. Paper presented at the second meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans, Washington, DC.
78. IOM (Institute of Medicine). 1994. Veterans and Agent Orange: Health effects of herbicides used in Vietnam. Washington, DC: National Academy Press.
79. IOM. 1996. Veterans and Agent Orange: Update 199 6. Washington, DC: National Academy Press.
80. IOM. 1999. Veterans and Agent Orange: Update 1998. Washington, DC: National Academy Press.
81. IOM. 2000. Gulf War and health, volume 1: Depleted uranium, pyridostigmine bromide, sarin, vaccines. Washington, DC: National Academy Press.
82. IOM. 2000. Veterans and Agent Orange: Herbicide/dioxin exposure and type 2 diabetes. Washington, DC: National Academy Press.
83. IOM. 2001. Veterans and Agent Orange: Update 2000. Washington, DC: National Academy Press.
84. IOM. 2003. Gulf War and health, volume 2: Insecticides and solvents. Washington, DC: The National Academies Press.
85. IOM. 2003. Veterans and Agent Orange: Update 2002. Washington, DC: The National Academies Press.
86. IOM. 2004. Gulf War and health: Updated literature review of sarin. Washington, DC: The National Academies Press.
87. IOM. 2004. Veterans and Agent Orange: Length of presumptive period for association between exposure and respiratory cancer. Washington, DC: The National Academies Press.
88. IOM. 2005. Gulf War and health, volume 3: Fuels, combustion products, propellants. Washington, DC: The National Academies Press.
89. IOM. 2005. Veterans and Agent Orange: Update 2004. Washington, DC: The National Academies Press.
90. IOM. 2006. Disposition of the Air Force Health Study. Washington, DC: The National Academies Press.
91. IOM. 2006. Gulf War and health, volume 4: Health effects of serving in the Gulf War. Washington, DC: The National Academies Press.
92. IOM. 2007. Gulf War and health, volume 5: Infectious diseases. Washington, DC: The National Academies Press.
93. IOM. 2007. Veterans and Agent Orange: Update 2006. Washington, DC: The National Academies Press.
94. Johnson, C. W. 2003. How our laws are made, revised and updated. Washington, DC: Government Printing Office. http://www.senate.gov/reference/resources/ pdf/howourlawsaremade. pdf (accessed May 7, 2007).
95. Kinderman, Q. 2006. Statement presented at the second meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans. Washington, DC.
96. Martinez, R. 2006. Institute of Medicine: Agent Orange and Gulf War studies. Presented at the second meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans, Washington, DC.
97. McLenachen, D. 2005. Presumptive service connection in VBA. Presented to Veterans' Disability Benefits Commission, Washington, DC.
98. NAS (The National Academies). 2007. The National Academies: Advisors to the nation on science, engineering, medicine. http://www.nationalacademies.org/ (accessed May 9, 2007).
99. NAS. 2007. The National Academies study process: Ensuring independent, objective advice. http://www.nationalacademies.org/studycommitteprocess.pdf (accessed May 9, 2007).
100. Overstreet, H. G. 2006. Statement presented at the third meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans. San Antonio, TX.
101. Pamperin, T. J. 2006. An overview of the disability benefits program and presumptions affecting veterans' benefits. Paper presented at the first meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans, Washington, DC.
102. Pamperin, T. J. 2006. Presumptions in VA's disability program-The effect. Paper presented at the first meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans, Washington, DC.
103. Petrou, L. 2006. Statement presented at the third meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans. San Antonio, TX.
104. Ryan, P. 2006. Perspectives on veterans' legislative disability presumptions. Paper presented at the third meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans, San Antonio, TX.
105. Scott, E. P. 2006. Statement presented at the third meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans, San Antonio, TX.
106. Selfon, L. J. 2006. Statement from the United Spinal Association presented at the second meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision- Making Process for Veterans, Washington, DC.
107. Sullivan, P. 2006. Testimony presented at the third meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans, San Antonio, TX.
108. VA (Department of Veterans Affairs). 2006. Internal VA process for reviewing reports of the IOM under the Agent Orange Act of 199 1 and the Persian Gulf War Veterans Acts of 1998. Presented to the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans, Washington, DC.
109. VA. 2007. Fiscal year 2008 budget submission. National cemetery administration, benefits program, departmental administration. Vol. 2. Washington, DC: Department of Veterans Affairs. http://www.va.gov/budget/summary/ (accessed May 9, 2007).
110. VBA (Veterans Benefits Administration). 2006. Annual benefits report fiscal year 2005. Washington, DC: Department of Veterans Affairs.
111. Violante, J. A. 2006. Public comments for the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans. San Antonio, TX.
112. Yoder, C. 2006. Thoughts on presumptions of service-connection for veterans presumed to have been exposed to environmental hazards. Paper presented at the third meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans, San Antonio, TX.
113. Brown, M. 2005. The role of science in Department of Veterans Affairs disability compensation policies for environmental and occupational illness and injuries. Journal of Law and Policy 13(2):593-612.
114. Brown, M. 2006. The role of science in Department of Veterans Affairs disability compensation policies for environmental and occupational illness and injuries. Paper presented to the IOM's Committee on Evaluation of the Presumptive Disability Decision-Making Process for Veterans, Washington, DC.
115. Hertz-Picciotto, I. 2005. How scientists view causality and assess evidence: A study of the Institute of Medicine's evaluation of health effects in Vietnam veterans and Agent Orange. Journal of Law and Policy (Brooklyn Law School) 13(2):553-591.
116. IOM (Institute of Medicine). 1994. Veterans and Agent Orange: Health effects of herbicides used in Vietnam. Washington, DC: National Academy Press.
117. IOM. 1996. Veterans and Agent Orange: Update 199 6. Washington, DC: National Academy Press.
118. IOM. 2000. Gulf War and health, volume 1: Depleted uranium, pyridostigmine bromide, sarin, vaccines. Washington, DC: National Academy Press.
119. IOM. 2000. Veterans and Agent Orange: Herbicide/dioxin exposure and type 2 diabetes. Washington, DC: National Academy Press.
120. IOM. 2003. Gulf War and health, volume 2: Insecticides and solvents. Washington, DC: The National Academies Press.
121. IOM. 2005. Gulf War and health, volume 3: Fuels, combustion products, propellants. Washington, DC: The National Academies Press.
122. IOM. 2006. Gulf War and health, volume 4: Health effects of serving in the Gulf War. Washington, DC: The National Academies Press.
123. IOM. 2007. Gulf War and health, volume 5: Infectious diseases. Washington, DC: The National Academies Press.
124. Murphy, S. 1986. A critique of the Veterans Administration claims process. Brooklyn Law Review 52:533-569.
125. NRC (National Research Council). 2003. A review of the dose reconstruction program of the Defense Threat Reduction Agency. Washington, DC: The National Academies Press.
126. Podgor, M. F. 2005. The inability of World War II atomic veterans to obtain disability benefits: Time is running out on our chance to fix the system. Elder Law Journal 13(2):519-523.
127. Reagan, R. 1984. Statement on signing the Veterans' Dioxin and Radiation Exposure Compensation Standards Act. http://www.presidency.ucsb.edu/ws/ index.php?pid=39308&st=&st1= (accessed May 15, 2007).
128. Stellman, J. M., S. D. Stellman. 2005. Characterization of exposure to Agent Orange in Vietnam veterans as a basis for epidemiological studies. Journal of Law and Policy (Brooklyn Law School) 13(2):505-525.
129. U.S. Congress, House of Representatives. 1984. Agent Orange and Atomic Veterans Relief Act. House Report 98-592. 98th Cong., 2nd Sess. January 25.
130. VA (Department of Veterans Affairs). 1985. Adjudication of claims based on exposure to dioxin or ionizing radiation. Final rules. Federal Register 50(165):34452-34461.
131. VA. 1996. Diseases associated with exposure to certain herbicide agents (prostate cancer and acute and subacute peripheral neuropathy). Final rule. Federal Register 61(217):57586-57589.
132. VA. 2001. Diseases associated with exposure to certain herbicide agents: Type 2 diabetes. Federal Register 66(89):23166-23169.
133. VA. 2002. Diseases specific to radiation-exposed veterans. Final rule. Federal Register 67(17):3612-3616.
134. VA. 2005. VA M21-1MR Adjudication Procedures Manual Rewrite. Washington, DC: Department of Veterans Affairs. http://www.warms.vba.va.gov/M21_1MR.html (accessed May 14, 2007).
135. VA. 2006. Extension of the presumptive period for compensation for Gulf War veterans. Federal Register 71(242):75669-75672.
136. VA. 2006. General provisions. Proposed rule. Federal Register 71(62):16464-16475.
137. Zeglin, D. E. 2006. Presumptions of service connection. Paper prepared for the Veterans' Disability Benefits Commission. https://www.1888932-2946.ws/vetscommission/ e-documentmanager/gallery/Documents/Reference:Materials/Presumption-Paper_3-7- 06.pdf (accessed March 8, 2007).
138. Beebe, G. W. 1975. Follow-up studies of World War II and Korean War prisoners. American Journal of Epidemiology 101(5):400-422.
139. Berkowitz, E. D., M. J. Santangelo. 1999. The Medical Follow-up Agency: The first fifty years 194 6-199 6. Washington, DC: National Academy Press.
140. Brass, L. M., W. F. Page. 1996. Stroke in former prisoners of war. Journal of Stroke and Cerebrovascular Diseases 6(2):72-78.
141. CDC (Centers for Disease Control and Prevention). 1988. Vietnam experience study-Psychosocial characteristics. Journal of the American Medical Association 259(18):2701-2707.
142. CIRRPC (Committee on Interagency Radiation Research and Policy Coordination). 1988. Use of probability of causation by the Veterans Administration in the adjudication of claims of injury due to exposure to ionizing radiation. Washington, DC: Office of Science and Technology Policy, Executive Office of the President.
143. Cohen, B. M., M. Z. Cooper. 1954. A follow-up study of World War II prisoners of war. Washington, DC: U.S. Government Printing Office.
144. DoD (Department of Defense). 1997. Implementation and application of joint medical surveillance for deployments. Instruction number 6490.3. Washington, DC: Department of Defense.
145. DoD. 2006. Deployment health. Instruction number 6490.03. Washington, DC: Department of Defense.
146. Engdahl, B. E., W. F. Page. 1991. Psychological effects of military captivity. In Epidemiology in military and veterans populations: Proceedings of the second biennial conference, March 7, 199 0, edited by W. F. Page. Washington, DC: National Academy Press. Pp. 49-66.
147. GAO (Government Accountability Office). 2004. Report to congressional requesters. Defense health care: Force health protection and surveillance policy compliance was mixed, but appears better for recent deployments. GAO-05-120. Washington, DC: Government Accountability Office. http://www.gao.gov/new.items/d05120.pdf (accessed March 19, 2007).
148. GAO. 2006. Military disability evaluation: ensuring consistent and timely outcomes for reserve and active duty members. GAO-06-561T. Washington, DC: United States Government Accountability Office. http://www.gao.gov/new.items/d06561t.pdf (accessed February 28, 2007).
149. GAO. 2006. VA and DOD health care: Efforts to provide seamless transition of care for OEF and OIF servicemembers and veterans. GAO-06-794R. Washington, DC: United States Government Accountability Office. http://www.gao.gov/htext/d06794r.html (accessed July 9, 2007).
150. Hrubec, Z., R. Ryder. 1980. Traumatic limb amputation and subsequent mortality from cardiovascular disease and other causes. Journal of Chronic Disease 33(4):239-250.
151. IARC (International Agency for Research on Cancer). 2000. Ionizing radiation, part 1: X- and gamma (g)-radiation, neutrons. Lyon, France: International Agency for Research on Cancer.
152. IARC. 2006. IARC monographs on the evaluation of carcinogenic risk to humans: Preamble. Lyon, France: International Agency for Research on Cancer. http://monographs.iarc. fr/ENG/Preamble/CurrentPreamble.pdf (accessed March 1, 2007).
153. IOM (Institute of Medicine). 1992. The health of former prisoners of war. Washington, DC: National Academy Press.
154. IOM. 1993. Veterans at risk: The health effects of mustard gas and lewisite. Washington, DC: National Academy Press.
155. IOM. 1994. Veterans and Agent Orange: Health effects of herbicides used in Vietnam. Washington, DC: National Academy Press.
156. IOM. 1996. Mortality of veteran participants in the CROSSROADS nuclear test. Washington, DC: National Academy Press.
157. IOM. 1996. Veterans and Agent Orange: Update 199 6. Washington, DC: National Academy Press.
158. IOM. 1999. Veterans and Agent Orange: Update 1998. Washington, DC: National Academy Press.
159. IOM. 2000. Gulf War and health, volume 1: Depleted uranium, pyridostigmine bromide, sarin, vaccines. Washington, DC: National Academy Press.
160. IOM. 2000. Veterans and Agent Orange: Herbicide/dioxin exposure and type 2 diabetes. Washington, DC: National Academy Press.
161. IOM. 2001. Veterans and Agent Orange: Update 2000. Washington, DC: National Academy Press.
162. IOM. 2002. The Five Series Study: Mortality of military participants in U.S. nuclear weapons tests. Washington, DC: The National Academies Press.
163. IOM. 2003. Gulf War and health, volume 2: Insecticides and solvents. Washington, DC: The National Academies Press.
164. IOM. 2003. Veterans and Agent Orange: Update 2002. Washington, DC: The National Academies Press.
165. IOM. 2005. Gulf War and health, volume 3: Fuels, combustion products, propellants. Washington, DC: The National Academies Press.
166. IOM. 2005. Veterans and Agent Orange: Update 2004. Washington, DC: The National Academies Press.
167. IOM. 2006. Gulf War and health, volume 4: Health effects of serving in the Gulf War. Washington, DC: The National Academies Press.
168. IOM. 2007. Gulf War and health, volume 5: Infectious diseases. Washington, DC: The National Academies Press.
169. Keehn, R. J. 1980. Follow-up studies of World War II and Korean Conflict prisoners. III. Mortality to January 1, 1976. American Journal of Epidemiology 111(2):194-211.
170. Kurtzke, J. F., W. F. Page. 1997. Epidemiology of multiple sclerosis in U.S. veterans: 7. Risk factors for MS. Neurology 48(1):204-213.
171. Kurtzke, J. F., G. W. Beebe, J. E. Norman, Jr. 1979. Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, geographic distribution. Neurology 29(9):1228-1235.
172. Kurtzke, J. F., G. W. Beebe, J. E. Norman, Jr. 1985. Epidemiology of multiple sclerosis in U.S. veterans: 3. Migration and the risk of MS. Neurology 35(5):672-678.
173. Kurtzke, J. F., W. F. Page, F. M. Murphy, J. E. Norman, Jr. 1992. Epidemiology of multiple sclerosis in U.S. veterans: 4. Age at onset. Neuroepidemiology 11(4-6):226-235.
174. Lagakos, S., F. Mosteller. 1986. Assigned shares in compensation for radiation-related cancers. Risk Analysis 6(3):345-380.
175. Lubin, J. H., K. Steindorf. 1995. Cigarette use and the estimation of lung cancer attributable to radon in the United States. Radiation Research 141(1):79-85.
176. Nefzger, M. D. 1970. Follow-up studies of World War II and Korean war prisoners. I. Study plan and mortality findings. American Journal of Epidemiology 91(2):123-138.
177. Norman, J. E., Jr., J. F. Kurtzke, G. W. Beebe. 1983. Epidemiology of multiple sclerosis in U.S. veterans: 2. Latitude, climate and the risk of multiple sclerosis?. Journal of Chronic Diseases 36(8):551-559.
178. NRC (National Research Council). 1980. The effects on populations of exposure to low levels of ionizing radiation. Washington, DC: National Academy Press.
179. NRC. 1984. Assigned share for radiation as a cause of cancer: Review of radioepidemiological tables assigning probability of causation. Washington, DC: National Academy Press.
180. NRC. 2003. A review of the dose reconstruction program of the Defense Threat Reduction Agency. Washington, DC: The National Academies Press.
181. NRC. 2005. Assessment of the scientific information for the Radiation Exposure Screening and Education Program. Washington, DC: The National Academies Press.
182. NRC. 2006. Health risks from exposure to low levels of ionizing radiation: BEIR VII-Phase 2. Washington, DC: The National Academies Press.
183. Page, W. F., L. M. Brass. 2001. Long-term heart disease and stroke mortality among former American prisoners of war of World War II and the Korean Conflict: Results of a 50-year follow-up. Military Medicine 166(9):803-808.
184. Page, W. F., R. N. Miller. 2000. Cirrhosis mortality among former American prisoners of war of World War II and the Korean Conflict: Results of a 50-year follow-up. Military Medicine 165(10):781-785.
185. Page, W. F., A. M. Ostfeld. 1994. Malnutrition and subsequent ischemic heart disease in former prisoners of World War II and the Korean Conflict. Journal of Clinical Epidemiology 47(12):1437-1441.
186. Page, W. F., C. M. Tanner. 2000. Parkinson's disease and motor-neuron disease in former prisoners of war. Letter. Lancet 355(9206):843.
187. Page, W. F., B. E. Engdahl, R. E. Eberly. 1991. Prevalence and correlates of depressive symptoms among former prisoners of war. Journal of Nervous and Mental Disease 179(11):670-677.
188. Page, W. F., J. F. Kurtzke, F. M. Murphy, J. E. Norman, Jr. 1993. Epidemiology of multiple sclerosis in U.S. veterans: 5. Ancestry and the risk of multiple sclerosis. Annals of Neurology 33(6):632-639.
189. Page, W. F., T. M. Mack, J. F. Kurtzke, F. M. Murphy, J. E. Norman, Jr. 1995. Epidemiology of multiple sclerosis in U.S. veterans: 6. Population ancestry and surname ethnicity as risk factors for multiple sclerosis. Neuroepidemiology 14(6):286-296.
190. Page, W. F., B. E. Engdahl, R. E. Eberly, C. S. Fullerton, R. J. Ursano. 1997. Persistence of PTSD in former prisoners of war. In Posttraumatic stress disorder: Acute and long-term responses to trauma and disaster, edited by C. S. Fullerton and R. J. Ursano. Washington, DC: American Psychiatric Press. Pp. 147-158.
191. Podgor, M. F. 2007. The inability of World War II atomic veterans to obtain disability benefits: Time is running out on our chance to fix the system. Elder Law Journal 13(2):519-552.
192. Prentice, R. L., Y. Yoshimoto, M. W. Mason. 1983. Relationship of cigarette smoking and radiation exposure to cancer mortality in Hiroshima and Nagasaki. Journal of the National Cancer Institute 70(4):611-622.
193. President's Task Force to Improve Health Care Delivery for Our Nation's Veterans. 2003. A brief guide to the final report. Arlington, VA: President's Task Force to Improve Health Care Delivery for our Nation's Veterans. http://veterans.house.gov/spotlight/ShortTaskForceReport. pdf (accessed July 11, 2007).
194. RECAC (Radiation Exposure Compensation Act Committee). 1996. Final report of the Radiation Exposure Compensation Act Committee. Washington, DC: Human Radiation Interagency Working Group. http://www.hss.energy.gov/HealthSafety/ohre/roadmap/uranium/ index.html (accessed June 24, 2007).
195. UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation). 2000. Sources and effects of ionizing radiation. UNSCEAR 2000 Report Vol. II. New York: United Nations. VA (Department of Veterans Affairs). 1949. Veterans claims miscellaneous amendments. Federal Register 14(26):568-578.
196. VA. 1980. Study of former prisoners of war. Washington, DC: U.S. Government Printing Office.
197. VA. 1992. Claims based on chronic effects of exposure to mustard gas. Proposed Rule. Federal Register 57(10):1699-1700.
198. VA. 1992. Claims based on chronic effects of exposure to mustard gas. Final Rule. Federal Register 57(148):33875-33877.
199. VA. 1993. Analysis of presumptions of service connection. Washington, DC: Department of Veterans Affairs.
200. VA. 1994. Claims based on chronic effects of exposure to vesicant agents. Proposed Rule. Federal Register 59(15):3532-3534.
201. VA. 1994. Claims based on chronic effects of exposure to mustard gas or lewisite. Final Rule. Federal Register 59(159):42497-42500.
202. VA. 1994. Disease not associated with exposure to certain herbicide agents. Notice. Federal Register 59(2):341-346.
203. VA. 1996. Diseases associated with exposure to certain herbicide agents (prostate cancer and acute and subacute peripheral neuropathy). Final rule. Federal Register 61(217):57586-57589.
204. VA. 2002. Possible occupational health exposures of veterans involved in Project Shad tests. Veterans Health Administration and Under Secretary for Health information letter IL10- 2002-016. Washington, DC: Department of Veterans Affairs. http://www1.va.gov/shad/ docs/IL_10-2002-016.pdf (accessed February 28, 2007).
205. VA. 2004. Presumptions of service connection for diseases associated with service involving detention or internment as a prisoner of war. Interim final rule. Federal Register 69(194):60083-60090.
206. VA. 2005. Health effects among veterans exposed to mustard and lewisite chemical warfare agents. Under Secretary for Health Information letter IL 10-2005-004. www.va.gov/environagents/ docs/USHInfoLetterIL10-2005-004_March_14_2005.pfd (accessed February 27, 2007).
207. VA. 2006. Potential health effects among veterans involved in military chemical warfare agent experiments conducted from 1955 to 1975. Under Secretary for Health information letter IL 10-2006-010. Washington, DC: Department of Veterans Affairs. http://www1.va.gov/ environagents/docs/USHInfoLetterIL10-2006-010.pdf (accessed February 28, 2007).
208. VA Multiple Sclerosis Study Group. 1956. Isoniazid in the treatment of multiple sclerosis: Report on VA Cooperative Study. Transactions of the American Neurological Association (81st meeting):128-131.
209. VA Multiple Sclerosis Study Group. 1957. Isoniazid in the treatment of multiple sclerosis: Report on Veterans Administration Cooperative Study. Journal of the American Medical Association 163(3):168-172.
210. Wallin, M. T., W. F. Page, J. F. Kurtzke. 2000. Epidemiology of multiple sclerosis in U.S. veterans: 8. Long-term survival after onset of multiple sclerosis. Brain 123(Pt. 8):1677-1687.
211. Pamperin, T. J. 2006. An overview of the disability benefits program and presumptions affecting veterans' benefits. Paper presented at the first meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans, Washington, DC.
212. Petrou, L. 2006. Statement presented at the third meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans. San Antonio, TX.
213. Ryan, P. 2006. Perspectives on veterans' legislative disability presumptions. Paper presented at the third meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans, San Antonio, TX.
214. Scott, E. P. 2006. Statement presented at the third meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans. San Antonio, TX.
215. VA (Department of Veterans Affairs). 2002. Veterans health initiative. Independent study course. Vietnam veterans and Agent Orange exposure. Washington, DC: Department of Veterans Affairs. http://www1.va.gov/agentorange/docs/VHIagentorange.pdf (accessed May 12, 2007).
216. Yoder, C. 2006. Thoughts on presumptions of service-connection for veterans presumed to have been exposed to environmental hazards. Paper presented at the third meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans, San Antonio, TX.
217. DHHS/CDC (Department of Health and Human Services/Centers for Disease Control and Prevention). 2004. The health consequences of smoking: A report of the Surgeon General. http://www.cdc.gov/tobacco/data_statistics/sgr/sgr_2004/index.htm (accessed July 27, 2007).
218. Doll, R., A. B. Hill. 1954. The mortality of doctors in relation to their smoking habits; A preliminary report. British Medical Journal 1(4877):1451-1455.
219. EPA (Environmental Protection Agency). 2005. Guidelines for carcinogen risk assessment. EPA/630/P-03/001B. Washington, DC: Environmental Protection Agency. http://www. epa.gov/IRIS/cancer032505.pdf (accessed March 1, 2007).
220. Golden, R., D. Pyatt, P. G. Shields. 2006. Formaldehyde as a potential human leukemogen: An assessment of biological plausibility. Critical Reviews in Toxicology 36(2):135-153.
221. Greenland, S. 1996. Basic methods for sensitivity analysis of biases. International Journal of Epidemiology 25(6):1107-1116.
222. Greenland, S. 2000. An introduction to instrumental variables for epidemiologists. International Journal of Epidemiology 29(4):722-729; Erratum 29(6):1102.
223. Greenland, S., D. Thomas. 1982. On the need for the rare disease assumption in casecontrol studies. American Journal of Epidemiology 116(3):547-553.
224. Hill, A. B. 1965. The environment and disease: Association or causation? Proceedings of the Royal Society of Medicine 58:295-300.
225. Hoeting, J., D. Madigan, A. Raftery, C. Volinsky. 1999. Bayesian model averaging. Statistical Science 14:382-401.
226. IARC (International Agency for Research on Cancer). 1999. IARC monographs on the evaluation of carcinogenic risk to humans: Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide. Vol. 71. http://monographs.iarc.fr/ENG/Monographs/vol71/volume71. pdf (accessed March 1, 2007).
227. IARC. 2006. IARC monographs on the evaluation of carcinogenic risk to humans: Formaldehyde, 2-butoxyethanol and 1-tert-butoxypropan-2-ol. Lyon, France: International Agency for Research on Cancer. http://monographs.iarc.fr/ENG/Monographs/vol88/volume88. pdf (accessed August 22, 2007).
228. IARC. 2006. IARC monographs on the evaluation of carcinogenic risk to humans: Preamble. Lyon, France: International Agency for Research on Cancer. http://monographs.iarc. fr/ENG/Preamble/CurrentPreamble.pdf (accessed March 1, 2007).
229. IOM (Institute of Medicine). 2006. Food marketing to children and youth: Threat or opportunity. Washington, DC: The National Academies Press.
230. IOM. 2006. Asbestos: Selected cancers. Washington, DC: The National Academies Press.
231. IOM/NRC (National Research Council). 2005. Dietary supplements: A framework for evaluating safety. Washington, DC: The National Academies Press.
232. Kennedy, P. 2003. A guide to econometrics. 5th ed. Cambridge, MA: MIT Press.
233. Koch, R. 1884. Die aetiologie der tuberkulose. Mittheilungen aus dem Kaiserlichen Gesundheitsamte 2:1-88.
234. Leamer, E. E. 1978. Specification searches: Ad hoc inference with nonexperimental data. New York: John Wiley & Sons.
235. Manski, C. 1995. Identification problems in the social sciences. Cambridge, MA: Harvard University Press.
236. Mill, J. S. 1862. A system of logic: Ratiocinative and inductive, being a connected view of the principle of evidence, the methods of scientific investigation. 5th ed. London, UK: Parker, Son and Bowin.
237. NTP (National Toxicology Program). 2005. Report on carcinogens. 11th ed. Washington, DC: National Toxicology Program. http://ntp.niehs.nih.gov/index.cfm?objectid=32BA9724- F1F6-975E-7FCE50709CB4C932 (accessed March 1, 2007).
238. NTP CERHR (NTP Center for the Evaluation of Risks to Human Reproduction). 2003. NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Di-n-Butyl Phthalate (DBP). Research Triangle Park, NC: NTP CERHR, U.S. Department of Health and Human Services.
239. NTP CERHR. 2005. Guidelines for CERHR Expert Panel Members. Research Triangle Park, NC: NTP CERHR, U.S. Department of Health and Human Services.
240. Rosenbaum, P. R. 2002. Observational studies. 2nd ed. New York: Springer-Verlag. Rothman, K. J. 1976. Causes. American Journal of Epidemiology 104(6):587-592.
241. Rothman, K. J. 2002. Epidemiology: An introduction. Oxford, UK: Oxford University Press.
242. Straif, K., R. Baan, Y. Grosse, B. Secretan, F. E. Ghissassi, V. Cogliano. 2005. Carcinogenicity of polycyclic aromatic hydrocarbons. Lancet Oncology 6(12):931-932.
243. Bayne-Jones, S., W. J. Burdette, W. G. Cochran, E. Farber, L. F. Fieser, J. Furth, J. B. Hickam, C. LeMaistre, L. M. Schuman, M. H. Seevers. 1964. Smoking and health. Report of the Advisory Committee to the Surgeon General of the Public Health Service. Public Health Services Publication No. 1103. Washington, DC: Public Health Service. http:// www.cdc.gov/tobacco/sgr/sgr_1964/sgr64.htm (accessed February 13, 2007).
244. Berlin, J. A., E. M. Antman. 1994. Advantages and limitations of metaanalytic regressions of clinical trials data. Online Journal of Current Clinical Trials. Doc. No. 134.
245. Berlin, J., T. C. Chalmers. 1988. Commentary on meta-analysis in clinical trials. Hepatology 8:690-691.
246. Cogliano, V. J. 2006. IARC monographs on the evaluation of carcinogenic risks to humans. Slideshow. http://www.oehha.ca.gov/prop65/public_meetings/pdf/IARCVJCogliano121206. pdf. (accessed May 14, 2007).
247. DHHS/CDC (Department of Health and Human Services/Centers for Disease Control and Prevention). 2004. The health consequences of smoking: A report of the Surgeon General. http://www.cdc.gov/tobacco/data_statistics/sgr/sgr_2004/index.htm (accessed July 27, 2007).
248. Dickersin, K., J. A. Berlin. 1992. Meta-analysis: State-of-the-science. Epidemiology Review 14:154-176.
249. EPA (Environmental Protection Agency). 2005. Guidelines for carcinogen risk assessment. EPA/630/P-03/001F. Washington, DC: EPA Risk Assessment Forum.
250. Greenland, S. 1994. Can meta-analysis be salvaged? American Journal of Epidemiology 140:783-787.
251. Greenland, S. 1994. Invited commentary: A critical look at some popular meta-analytic methods. American Journal of Epidemiology 140:290-296.
252. Greenland, S., K. O'Rourke. 2001. On the bias produced by quality scores in meta- analysis, a hierarchical view of proposed solutions. Biostatistics 2:463-471.
253. Howson, C., P. Urbach. 1989. Scientific reasoning: The Bayesian approach. Peru, IL: Open Court Publishing Company.
254. IARC (International Agency for Research on Cancer). 1987. IARC monographs on the evaluation of carcinogenic risks to humans overall evaluations of carcinogenicity: An updating of IARC Monographs. Vol. 1 to 42. Supplement 7. http://monographs.iarc. fr/ENG/Monographs/suppl7/suppl7.pdf (accessed May 4, 2007).
255. IARC. 1997. Polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans. IARC monographs on the evaluations of carcinogenic risks to humans. Vol. 69. http://monographs. iarc.fr/ENG/Monographs/vol69/volume69.pdf (accessed May 4, 2007).
256. IARC. 1999. IARC Monographs on the evaluation of carcinogenic risks to humans. Some chemicals that cause tumours of the kidney or urinary bladder in rodents and some other substances. Summary of data reported and evaluation. Vol. 73. http://monographs.iarc. fr/ENG/Monographs/vol73/volume73.pdf (accessed May 4, 2007).
257. IARC. 2004. IARC classifies formaldehyde as carcinogenic to humans. Press Release No. 153. http://www.iarc.fr/ENG/Press_Releases/archives/pr153a.html (accessed February 13, 2007).
258. IARC. 2006. Formaldehyde, 2-butoxyethanol and 1-tert-butoxypropan-2-ol. IARC monograph. Vol. 88. http://monographs.iarc.fr/ENG/Monographs/vol88/volume88.pdf (accessed February 13, 2007).
259. IARC. 2006. IARC monographs on the evaluation of carcinogenic risks to humans: Preamble. Lyon, France: World Health Organization/International Agency for Research on Cancer. http://monographs.iarc.fr/ENG/Preamble/CurrentPreamble.pdf (accessed February 13, 2007).
260. IOM (Institute of Medicine). 1994. Veterans and Agent Orange: Health effects of herbicides used in Vietnam. Washington, DC: National Academy Press.
261. IOM. 1996. Veterans and Agent Orange: Update 199 6. Washington, DC: National Academy Press.
262. IOM. 1999. Veterans and Agent Orange: Update 1998. Washington, DC: National Academy Press.
263. IOM. 2000. Gulf War and health, volume 1: Depleted uranium, pyridostigmine bromide, sarin, vaccines. Washington, DC: National Academy Press.
264. IOM. 2001. Veterans and Agent Orange: Update 2000. Washington, DC: National Academy Press.
265. IOM. 2003. Gulf War and health, volume 2: Insecticides and solvents. Washington, DC: The National Academies Press.
266. IOM. 2003. Veterans and Agent Orange: Update 2002. Washington, DC: The National Academies Press.
267. IOM. 2004. Gulf War and health: Updated literature review of sarin. Washington, DC: The National Academies Press.
268. IOM. 2005. Gulf War and health, volume 3: Fuels, combustion products, propellants. Washington, DC: The National Academies Press.
269. IOM. 2005. Veterans and Agent Orange: Update 2004. Washington, DC: The National Academies Press.
270. IOM. 2006. Asbestos: Selected cancers. Washington, DC: The National Academies Press.
271. IOM. 2006. Gulf War and health, volume 4: Health effects of serving in the Gulf War. Washington, DC: The National Academies Press.
272. IOM. 2007. Gulf War and health, volume 5: Infectious diseases. Washington, DC: The National Academies Press.
273. IOM/NRC (National Research Council). 2005. Dietary supplements: A framework for evaluating safety. Washington, DC: The National Academies Press.
274. Kaizar, E. E. 2005. Meta-analyses are observational studies: How lack of randomization impacts analysis. American Journal of Gastroenterology 100:1233-1236.
275. NAS (National Academy of Sciences). 1988. Health risks of radon and other internally deposited alpha-emitters (Beir IV). Washington, DC: National Academy Press.
276. NIH (National Institutes of Health). 2000. Fact sheet: The report on carcinogens. 9th ed. http://www.nih.gov/news/pr/may2000/niehs-15.htm (accessed June 3, 2007).
277. NTP (National Toxicology Program). 2005. Report on carcinogens. 11th report on Carcinogens. Research Triangle Park, NC: NTP.
278. NTP CERHR (NTP Center for the Evaluation of Risks to Human Reproduction). 2003. NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Di-n-Butyl Phthalate (DBP). Research Triangle Park, NC: NTP CERHR, U.S. Department of Health and Human Services.
279. NTP CERHR. 2005. Guidelines for CERHR Expert Panel Members. Research Triangle Park, NC: NTP CERHR, U.S. Department of Health and Human Services.
280. Shelby, M.D. 2005. National Toxicology Program Center for the Evaluation of Risks to Human Reproduction: Guidelines for CERHR Expert Panel Members. Birth Defects Research (Part B) 74:9-16.
281. Stram, D. O. 1996. Meta-analysis of published data using a linear mixed-effects model. Biometrics 52:536-544.
282. Stroup, D. F., J. A. Berlin, S. C. Morton, I. I. Olkin, G. D. Williamson, D. Rennie, D. Moher, B. J. Becker, T. A. Sipe, S. B. Thacker. 2000. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. Journal of the American Medical Association 283: 2008-2012.
283. Austin, H., Delzell, E., Cole, P. 1988. Benzene and leukemia: A review of the literature and a risk assessment. American Journal of Epidemiology 127:419-439.
284. Benichou, J. 2001. A review of adjusted estimators of attributable risk. Statistical Methods in Medical Research 10:195-216.
285. Bruzzi, P., S. B. Green, D. P. Byar, L. A. Brinton, C. Schairer. 1985. Estimating the population attributable risk for multiple risk factors using case-control data. American Journal of Epidemiology 122(5):904-914.
286. Cox, A. T. 1984. Probability of causation and the attributable proportion of risk. Risk Analysis 4(3):221-230.
287. Cox, A. T. 1987. Statistical issues in the estimation of assigned shares for carcinogenesis liability. Risk Analysis 7(1):71-80.
288. DHHS (Department of Health and Human Services). 2002. 42 CFR Parts 81 and 82. Guidelines for determining the probability of causation and methods for radiation dose reconstruction under the Employees Occupational Illness Compensation Program Act of 2000; Final Rules. Federal Register 67(85):22296-22330.
289. Greenland, S. 1999. Relation of probability of causation to relative risk and doubling dose: A methodologic error that has become a social problem. American Journal of Public Health 89:1166-1169.
290. Greenland, S., J. M. Robins. 1988. Conceptual problems in the definition and interpretation of attributable fractions. American Journal of Epidemiology 128:1185-1197.
291. Greenland, S., J. M. Robins. 2000. Epidemiology, justice and the probability of causation. Jurimetrics 40:321-340.
292. Lagakos, S. W., F. Mosteller. 1986. Assigned shares in compensation for radiation-related cancers. Risk Analysis 6(3):345-357.
293. NCI (National Cancer Institute). 2006. Lung cancer prevention. http://www.cancer.gov/ cancertopics/ pdq/prevention/lung/Patient/page2 (accessed May 23, 2007).
294. NIH (National Institutes of Health). 1985. Report of the National Institutes of Health Ad Hoc Working Group to Develop Radioepidemiological Tables. Responding to the congressional mandate under Section 7(b) of the Orphan Drug Act of January 4, 1983 (PL- 97 -414). NIH Pub. No. 85-2748. Washington, DC: U.S. Government Printing Office.
295. NIOSH (National Institute of Occupational Safety and Health). 2007. Users guide for the Interactive RadioEpidemiological Program (NIOSH-IREP). Version 5.5.2. http://0-www. cdc.gov.mill1.sjlibrary.org/niosh/ocas/pdfs/irep/irepug0607.pdf (accessed July 28, 2007).
296. NRC (National Research Council). 1984. Assigned share for radiation as a cause of cancer, review of radioepidemiologic tables assigning probabilities of causation. Washington, DC: National Academy Press.
297. NRC. 2000. A review of the draft report of the NCI-CDC Working Group to Revise the 1985 Radioepidemiological Tables. Washington, DC: National Academy Press.
298. Obuchowski, N. A. 2003. Receiver operating characteristic curves and their use in radiology. Radiology 229:3-8.
299. OEHHA (Office of Environmental Health Hazard Assessment). 2001. Public health goal for benzene in drinking water. California Environmental Protection Agency. http://www. oehha.ca.gov/water/phg/pdf/BenzeneFinPHG.pdf (accessed February 7, 2007).
300. Oh, W. K., Hurwitz, M., D'Amico, A. V., Richie, J. P., Kantoff, P. W. 2003. Neoplasms of the prostate (Ch. 111). In: Holland-Frei Cancer Medicine 6, 6th ed. Hamilton, ON: BC Decker.
301. OSTP (Office of Science Technology and Policy). 1988. Use of probability of causation by the Veterans Administration in the adjudication of claims of injury due to exposure to ionizing radiation. OSTP Committee on Interagency Radiation Research and Policy Coordination. Executive Office of the President, Washington, DC.
302. Presidential Commission. 1990. Ch. 4. Standards and procedures for latent illnesses. Presidential Commission on Catastrophic Nuclear Accidents: Report to Congress. Washington, DC.
303. Robins, J. 2004. Should compensation schemes be based on the probability of causation or expected years of life lost? Journal of Law and Policy 12:537-548.
304. Robins, J. M., S. Greenland. 1989. Estimability and estimation of excess and etiologic fractions. Statistics and Medicine 8:845-859.
305. Robins, J., S. Greenland. 1989. The probability of causation under a stochastic model for individual risk. Biometrics 45:1125-1138.
306. Robins, J., S. Greenland. 1991. Estimability and estimation of expected years of life lost due to a hazardous exposure. Statistics and Medicine 10:79-93.
307. Rothman, K. J., S. Greenland. 1998. Modern Epidemiology, 2nd ed. Philadelphia, PA: Lippincott-Raven. Pp. 54-55.
308. Steenland, K., B. Armstrong. 2006. An overview of methods for calculating the burden of disease due to specific risk factors. Epidemiology 17(5):512-519.
309. Thomas, D. C. 2000. The probability of causation can be used in an equitable manner to resolve radiation tort claims and design compensation claims. Radiation Research 154(6):718-719.
310. AHRQ (Agency for Healthcare Research and Quality). 2006. Guide to clinical preventive services. Recommendations of the U.S. Preventive Services Task Force. AHRQ Publication No. 06-0588. Rockville, MD: AHRQ.
311. ASTM (American Society for Testing and Materials). 2003. Standard guide for environmental health site assessment process for military deployments. Designation E 23 18-03. West Conshohocken, PA: ASTM International.
312. ATSDR (Agency for Toxic Substances and Disease Registry). 2003. What Is the National Exposure Registry (NER)? http://www.atsdr.cdc.gov/NER/index.html (accessed April 6, 2007).
313. Breslau, N., E. L. Peterson, R. C. Kessler, L. R. Schultz. 1999. Short screening scale for DSMIV posttraumatic stress disorder. American Journal of Psychiatry 156(6):908-911.
314. Buydens-Branch, N. D., M. Branchey. 1990. Duration and intensity of combat exposure and posttraumatic stress disorder in Vietnam veterans. Journal of Nervous and Mental Disease 178:582-587.
315. Carlson, E. B. 2001. Psychometric study of a brief screen for PTSD: Assessing the impact of multiple traumatic events. Assessment 8(4):431-441.
316. CDC VES (Centers for Disease Control and Prevention Vietnam Experience Study). 1989. Health status of Vietnam veterans. Synopsis. Vol. 1. Atlanta, GA: Centers for Disease Control. http://www.cdc.gov/nceh/veterans/default1c.htm (accessed April 9, 2007).
317. Coffey, S. F., B. S. Dansky, S. A. Falsetti, M. E. Saladin, K. T. Brady. 1998. Screening for PTSD in a substance abuse sample: Psychometric properties of a modified version of the PTSD Symptom Scale Self-Report. Posttraumatic stress disorder. Journal of Traumatic Stress 11(2):393-399.
318. Cohen, B. M., M. Z. Cooper. 1954. A follow-up study of World War II prisoners of war. VA Medical Monograph. Washington, DC: U.S. Government Printing Office.
319. Do, N. 2006. DoD and Veterans Affairs: Health information sharing. Paper presented at the third meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans, San Antonio, TX.
320. DoD (Department of Defense). 1997. Instruction 649 0.3: Implementation and application of joint medical surveillance for deployments. Fort Sam Houston, TX: Army Medical Department Center and School.
321. DoD. 2004. Directive 649 0.2: Comprehensive health surveillance.
322. DoD. 2006. Defense Occupational and Environmental Health Readiness System (DOEHRS): Implementation and training (I&T) plan. PLN-002. Washington, DC: DOEHRS Project Management Office.
323. DoD. 2006. Defense Occupational and Environmental Health Readiness System (DOEHRS). Student Guide Version 1.0.2.0. Washington, DC: DOEHRS Project Management Office.
324. DoD. 2006. Instruction 649 0.03: Deployment health.
325. DoD. 2006. Periodic health assessment policy for active duty and selected reserve members. Memorandum for Assistant Secretary of the Army, Assistant Secretary of the Navy, Assistant Secretary of the Air Force. HA Policy 06-006. Washington, DC: Department of Defense.
326. DoD Industrial Hygiene Working Group. 2000. DoD industrial hygiene exposure assessment model. Report 2000-1. https://www.denix.osd.mil/denix/Public/News/Army/DOHP/Occhealth/ Documents/IHEAM/ihassessmodelv8.html (accessed July 28, 2007).
327. DoD/VHA (Veterans Health Administration). 2000. VHA Directive 1302: Agent Orange Registry (AOR) Program. Washington, DC: Department of Veterans Affairs/Veterans Health Administration. http://www1.va.gov/vhapublications/ViewPublication.asp?pub_ID=77 (accessed April 6, 2007).
328. DoD/VHA. 2005. VHA Handbook 1303.2: Gulf War (Including Operation Iraqi Freedom) Registry (GWR) Program-(formerly Persian Gulf Registry [GWR] Program). Washington, DC: Department of Veterans Affairs/Veterans Health Administration. http://www. vethealth.cio.med.va.gov/Pubs/1303.2GWHB-05.pdf (accessed April 6, 2007).
329. DoD/VHA. 2006. Ionizing Radiation Registry (IRR) Program procedures. Washington, DC: Department of Veterans Affairs/Veterans Health Administration. http://www1.va.gov/ irad/docs/IRADHANDBOOK012006.PDF (accessed April 9, 2007).
330. Dohrenwend, B. P., J. B. Turner, N. A. Turse, B. G. Adams, K. C. Koenen, R. Marshall. 2006. The psychological risks of Vietnam for U.S. veterans: A revisit with new data and methods. Science 313:979-982.
331. Friedman, M. J., C. K. Schneiderman, A. N. West, J. A. Corson. 1986. Measurement of combat exposure, posttraumatic stress disorder, life stress among Vietnam combat veterans. American Journal of Psychiatry 143:537-539.
332. Frueh, B. C., J. D. Elhai, A. L. Grubaugh, J. Monnier, T. B. Kashdan, J. A. Sauvageot, M. B. Hamner, B. G. Burkett, G. W. Arana. 2005. Documented combat exposure of U.S. veterans seeking treatment for combat-related post-traumatic stress disorder. British Journal of Psychiatry 186:467-472.
333. GAO (Government Accountability Office). 1999. Veterans' benefits claims: Further improvements needed in claims-processing accuracy. Report to the ranking minority member, Committee on Veterans' Affairs, House of Representatives. GAO/HEHS-99-35. Washington, DC: Government Accountability Office. http://www.gao.gov/archive/1999/he99035. pdf (accessed February 14, 2007).
334. GAO. 2000. Veterans Benefits Administration: Problems and challenges facing disability claims processing: Testimony before the Subcommittee on Oversight and Investigations, Committee on Veterans' Affairs, House of Representatives, Statement of Cynthia A. Bascetta, Association Director, Veterans' Affairs and Military Health Care Issues, Health, Education, Human Services Division. GAO/T-HEHS/AIMD-00-146. Washington, DC: Government Accountability Office. http://www.gao.gov/new.items/h100146t.pdf (accessed February 14, 2007).
335. GAO. 2000. Veterans' benefits: Promising claims-processing practices need to be evaluated. Report to ranking minority member, Committee on Veterans' Affairs, House of Representatives. GAO/HEHS-00-65. Washington, DC: Government Accountability Office. http://www.gao.gov/archive/2000/he00065.pdf (accessed February 14, 2007).
336. GAO. 2005. DoD and VA systematic data sharing would help expedite servicemembers' transition to VA services: Testimony before the Subcommittee on Oversight and Investigations, Committee on Veterans' Affairs, House of Representatives. Statement of Cynthia A. Bascetta. Director, Health Care-Veterans' Health and Benefits Issues. GAO-05-722T. Washington, DC: Government Accountability Office. http://www.gao.gov/new.items/ d05722t.pdf (accessed February 14, 2007).
337. GAO. 2005. Veterans' Benefits: Further changes in VBA's field office structure could help improve disability claims processing: Report to congressional requesters. GAO-06-149. Washington, DC: Government Accountability Office. http://www.gao.gov/new.items/ d06149.pdf (accessed February 14, 2007).
338. GAO. 2006. VA and DoD health care: Opportunities to maximize resource sharing remain. Report to congressional committees. GAO-06-315. Washington, DC: Government Accountability Office. http://www.gao.gov/new.items/d06315.pdf (accessed February 14, 2007).
339. GAO. 2007. VA and DoD are making progress in sharing medical information, but remain far from having comprehensive electronic medical records. GAO-07-1108T. Washington, DC: Government Accountability Office. http://www.gao.gov/new.items/d071108t.pdf (accessed July 27, 2007).
340. Goldberg, J., B. Curran, M. E. Vitek, W. G. Henderson, E. J. Boyko. 2002. The Vietnam Era Twin Registry. Twin Research 5(5):476-481.
341. Gray, G. C., K. B. Chesbrough, M. A. Ryan, P. Amoroso, E. J. Boyko, G. D. Gackstetter, T. I. Hooper, J. R. Riddle, Millennium Cohort Study Group. 2002. The millennium cohort study: A 21-year prospective cohort study of 140,000 military personnel. Military Medicine 167(6):483-488.
342. Green, B. L., J. D. Lindy, M. C. Grace, G. C. Gleser. 1989. Multiple diagnosis in posttraumatic stress disorder. The role of war stressors. Journal of Nervous and Mental Disease 177:329-335.
343. Heller, J. M. 2006. Deployment health surveillance: Past, current, future operations. Paper presented at the second meeting of the IOM's Committee on the Evaluation of Presumptive Disability Decision-Making Process for Veterans, Washington, DC.
344. Henderson, W. G., S. Eisen, J. Goldberg, W. R. True, J. E. Barnes, M. E. Vitek. 1990. The Vietnam Era Twin Registry: A resource for medical research. Public Health Reports 105(4):368-373.
345. Hoge, C. W., C. A. Castro, S. C. Messer, D. McGurk, D. I. Cotting, R. L. Koffman. 2004. Combat duty in Iraq and Afghanistan, mental health problems, barriers to care. New England Journal of Medicine 351:13-22.
346. IOM (Institute of Medicine). 1992. The health of former prisoners of war. Washington, DC: National Academy Press.
347. IOM. 1993. Veterans at risk: The health effects of mustard gas and lewisite. Washington, DC: National Academy Press.
348. IOM. 1994. Veterans and Agent Orange: Health effects of herbicides used in Vietnam. Washington, DC: National Academy Press.
349. IOM. 1995. Adverse reproductive outcomes in families of atomic veterans: The feasibility of epidemiologic studies. Washington, DC: National Academy Press.
350. IOM. 1995. Health consequences of service during the Persian Gulf War: Initial findings and recommendations for immediate action. Washington, DC: National Academy Press.
351. IOM. 1996. Health consequences of service during the Persian Gulf War: Recommendations for research and information systems. Washington, DC: National Academy Press.
352. IOM. 1996. Mortality of veteran participants in the CROSSROADS nuclear test. Washington, DC: National Academy Press.
353. IOM. 1997. Characterizing exposure of veterans to agent orange and other herbicides used in Vietnam: Scientific considerations regarding a request for proposals for research. Washington, DC: National Academy Press.
354. IOM. 1998. Adequacy of the VA Persian Gulf registry and uniform case assessment protocol. Washington, DC: National Academy Press.
355. IOM. 1998. Measuring the health of Persian Gulf veterans: Workshop summary. Washington, DC: National Academy Press.
356. IOM. 1999. Gulf War veterans: Measuring health. Washington, DC: National Academy Press.
357. IOM. 1999. Strategies to protect the health of deployed forces: Medical surveillance, record keeping, risk reduction. Washington, DC: National Academy Press.
358. IOM. 1999. Veterans and Agent Orange: Update 1998. Washington, DC: National Academy Press.
359. IOM. 2000. The five series study: Mortality of military participants in U.S. nuclear weapons tests. Washington, DC: National Academy Press.
360. IOM. 2000. Gulf War and health, volume 1: Depleted uranium, pyridostigmine bromide, sarin, vaccines. Washington, DC: National Academy Press.
361. IOM. 2000. Protecting Those Who Serve: Strategies to Protect the Health of the Deployed U.S. Forces. Washington, DC: National Academy Press.
362. IOM. 2000. Veterans and Agent Orange: Herbicide/dioxin exposure and type 2 diabetes. Washington, DC: National Academy Press.
363. IOM. 2001. Gulf War veterans: Treating symptoms and syndromes. Washington, DC: National Academy Press.
364. IOM. 2001. Veterans and Agent Orange: Update 2000. Washington, DC: National Academy Press.
365. IOM. 2002. Veterans and Agent Orange herbicide/dioxin exposure and acute myelogenous leukemia in the children of Vietnam veterans. Washington, DC: National Academy Press.
366. IOM. 2003. Characterizing exposure of veterans to Agent Orange and other herbicides used in Vietnam: Interim findings and recommendations. Washington, DC: The National Academies Press.
367. IOM. 2003. Characterizing exposure of veterans to Agent Orange and other herbicides used in Vietnam: Final Report. Washington, DC: The National Academies Press.
368. IOM. 2003. Gulf War and health, volume 2: Insecticides and solvents. Washington, DC: The National Academies Press.
369. IOM. 2003. Veterans and Agent Orange: Update 2002. Washington, DC: The National Academies Press.
370. IOM. 2004. Gulf War and health: Updated literature review of sarin. Washington, DC: The National Academies Press.
371. IOM. 2004. Studies of U.S. veterans twins. http://www.iom.edu/CMS/3795/4907.aspx (accessed February 14, 2007).
372. IOM. 2004. Veterans and Agent Orange: Length of presumptive period for association between exposure and respiratory cancer. Washington, DC: The National Academies Press.
373. IOM. 2005. Gulf War and health, volume 3: Fuels, combustion products, propellants. Washington, DC: The National Academies Press.
374. IOM. 2005. Veterans and Agent Orange: Update 2004. Washington, DC: The National Academies Press.
375. IOM. 2006. Gulf War and health, volume 4: Health effects of serving in the Gulf War. Washington, DC: The National Academies Press.
376. IOM. 2007. Gulf War and health, volume 5: Infectious diseases. Washington, DC: The National Academies Press.
377. Janes, G. R., J. Goldberg, S. A. Eisen, W. R. True. 1991. Reliability and validity of a combat exposure index for Vietnam era veterans. Journal of Clinical Psychology 47:80-86.
378. Kang, H. 2006 (July 27). VA health registries. Paper presented at the second meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans, Washington, DC.
379. Keane, T. M., J. A. Fairbank, J. M. Caddell, R. T. Zimering, K. L. Taylor, C. A. Mora. 1989. Clinical evaluation of a measure to assess combat exposure. Psychological Assessment 1:53-55.
380. Laufer, R. S., M. S. Gallops, E. Frey-Wouters. 1984. War stress and trauma: The Vietnam veteran experience. Journal of Health and Social Behavior 25:65-85.
381. Long, E. R., S. A. Jablon. 1955. Tuberculosis in the army of the United States in World War II. VA Medical Monograph. Washington, DC: U.S. Government Printing Office.
382. Lund, M., D. Foy, C. Sipprelle, A. Strachan. 1984. The Combat Exposure Scale: A systematic assessment of trauma in the Vietnam War. Journal of Clinical Psychology 40:1323-1328.
383. The Millennium Cohort Study. 2007. http://www.millenniumcohort.org/about.php (accessed July 24, 2007).
384. Postlewaite, C. 2006. Overview: DoD deployment and installation-based occupational/environmental health programs. Paper presented at the second meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans, Washington, DC.
385. Prins, A., P. Ouimette, R. Kimerling, R. P. Cameron, D. S. Hugelshofer, J. Shaw-Hegwer, A. Thrailkill, F. D. Gusman, J. I. Sheikh. 2004. The primary care PTSD screen (PC- PTSD): Development and operating characteristics. Primary Care Psychiatry 9(1):9-14.
386. Robinette, C. D., S. Jablon, T. L. Preston. 1985. Studies of participants in nuclear tests. Washington, DC: National Academy Press.
387. SMITREC (Serious Mental Illness Treatment Research and Evaluation Center). 2001. Care for veterans with psychosis in the VHA FY01: 3rd Annual National Psychosis Registry Report. Ann Arbor, MI: Serious Mental Illness Treatment Research and Evaluation Center, Health Services Research and Development Center of Excellence. http://www. hsrd.ann-arbor.med.va.gov/documents/3rdAn0nual_psychosisVHA.pdf (accessed April 6, 2007).
388. SMITREC. 2002. Specialty care for veterans with depression in the VHA: 2002 National Registry for Depression (NARDEP) Report. Ann Arbor, MI: Serious Mental Illness Treatment Research and Evaluation Center, Health Services Research and Development Center of Excellence. http://www.hsrd.ann-arbor.med.va.gov/documents/2002NARDEP. pdf (accessed April 6, 2007).
389. VA (Department of Veterans Affairs). 2003. Press release. VA begins registry for Lou Gehrig's Disease. http://www.research.va.gov/news/press_releases/lou-gehrig-021803.cfm (accessed April 5, 2007).
390. VA. 2005. Office of Research and Development Program announcement. Request for applications in combat casualty neurotrauma. http://www.research.va.gov/funding/solicitations/ docs/neurotrauma.pdf (accessed April 5, 2007).
391. VA. 2005. VA Form 10-10EZ. Application for health benefits. https://www.1010ez.med. va.gov/sec/vha/1010ez/Form/vha-10-10ez.pdf (accessed April 5, 2007).
392. VA. 2006. Fact sheet: Facts about the Department of Veterans Affairs. Washington, DC: Department of Veterans Affairs. http://www1.va.gov/OPA/fact/docs/vafacts.pdf (accessed April 9, 2007).
393. VA. 2006. Office of Research and Development Program announcement. Deployment health: OEF/OIF veteran research issues. http://www.research.va.gov/funding/solicitations/docs/ Deployment_Health_2006.pdf (accessed April 5, 2007).
394. VA. 2006. VA WRIISC-DC-Veterans Affairs War-Related Illness and Injury Study Center in Washington, DC. http://www.va.gov/WRIISC-DC/ (accessed April 5, 2007).
395. VA. 2007. Federal benefits for veterans and dependents. Washington, DC: Department of Veterans Affairs. http://www1.va.gov/opa/vadocs/fedben.pdf (accessed April 5, 2007).
396. VA. 2007. Seamless transition home. http://www.seamlesstransition.va.gov/ (accessed April 5, 2007).
397. VA. 2007. Seattle Epidemiologic Research and Information Center. http://www.eric.seattle. med.va.gov/index.html (accessed April 6, 2007).
398. VA. 2007. VA health care eligibility and enrollment: Getting care. http://www.va.gov/healtheligibility/ gettingcare/ (accessed April 5, 2007).
399. VA. 2007. Vietnam Era Twin Registry: Identification of Vietnam era veteran twins. http:// www.eric.seattle.med.va.gov/VETR/identification_of_twins.html (accessed April 6, 2007).
400. Walker, A. E., S. Jablon. 1961. A follow-up study of head wounds in World War II. VA Medical Monograph. Washington, DC: U.S. Government Printing Office.
401. Wessely, S., C. Unwin, M. Hotopf, L. Hull, K. Ismail, V. Nicolaou, A. David. 2003. Stability of recall of military hazards over time. Evidence from the Persian Gulf War of 1991. British Journal of Psychiatry 183:314-322.
402. Yehuda, R., S. M. Southwick, E. L. Giller, Jr. 1992. Exposure to atrocities and severity of chronic posttraumatic stress disorder in Vietnam combat veterans. American Journal of Psychiatry 149:333-336.
403. Zimmerman, M., J. I. Mattia. 2001. The Psychiatric Diagnostic Screening Questionnaire: Development, reliability, validity. Comprehensive Psychiatry 42(3):175-189.
404. ACHRE (Advisory Committee on Human Radiation Experiments). 1995. Final report. Washington, DC: Government Printing Office. http://hss.energy.gov/healthsafety/ohre/roadmap/ achre/report.html (accessed March 7, 2007).
405. Brown, M. 2003. VA charge to the IOM Oversight Committee on the Study of the Health of Participants in Project SHAD (Shipboard Hazard and Defense). Washington, DC: Department of Veterans Affairs. http://www1.va.gov/shad/docs/VA_Charge_IOM_on_ the_Health_Study_of_SHAD.pdf (accessed March 7, 2007).
406. Bush, G. W. 2003. Executive order 13292: Further amendment to executive order 12958, as amended, classified national security information. Federal Register 68(60):15315-15334. http://a257.g.akamaitech.net/7/257/2422/14mar20010800/edocket.access.gpo.gov/2003/ pdf/03-7736.pdf (accessed March 7, 2007).
407. Classification. 1936. Dictionary of Unites States Army terms: Army regulation 32 0-5. Attachment 2. Washington, DC: Government Printing Office. http://www.gwu.edu/~nsarchiv/ radiation/dir/mstreet/commeet/meet14/brief14/tab_d/br14d1b.txt (accessed March 7, 2007).
408. Clinton, W. J. 1995. Executive order 12958: Classified national security information. Federal Register 60(76):19825-19843. http://frwebgate.access.gpo.gov/cgi-bin/getdoc. cgi?dbname=1995_register&docid=fr20ap95-135.pdf (accessed March 7, 2007).
409. Do, N. 2006. DoD and Veterans Affairs: Health information sharing. Paper presented at the third meeting of the IOM's Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans, San Antonio, TX.
410. DoD (Department of Defense). 1997. Information Security Program. DoD 5200.1-R. Washington, DC: Office of the Assistant Secretary of Defense/Command, Control, Communications, Intelligence. http://www.fas.org/irp/doddir/dod/5200-1r/ (accessed March 7, 2007).
411. Freeman, C. 2006. Department of Veterans Affairs/Department of Defense: Health data systems interoperability. A presentation to the Institute of Medicine Committee on the Evaluation of the Presumptive Disability Decision-Making Process for Veterans, San Antonio, TX.
412. IOM (Institute of Medicine). 1993. Veterans at risk: The health effects of mustard gas and lewisite. Washington, DC: National Academy Press.
413. Pike, J. 2002. Security and classification. Gloucester, MA: Granite Island Group, Technical Surveillance Counter Measures. http://www.tscm.com/classification.html (accessed April 10, 2007).
414. Quist, A. S. 2002. Introduction, history, adverse impacts. Vol. 1. Oak Ridge, TN: Oak Ridge Classification Associates, LLC. http://www.fas.org/sgp/library/quist/index.html (accessed March 7, 2007).
415. Taylor, J. R., W. N. Johnson. 1975. Research report concerning the use of volunteers in chemical agent research. DAIG-IN 21-75. Washington, DC: Department of the Army, Office of the Inspector General and Auditor General.
416. Trials of war criminals before the Nuremberg military tribunals. 1949. Control Council Law 10(2):181-182. http://www.copernicusgroup.com/irbForms/NurembergCode.pdf (accessed March 7, 2007).
417. Truman, H. S. 1950. Executive order 10104: Defining certain vital military and naval installations and equipment as required protection against the general dissemination of information relative thereto. http://www.presidency.ucsb.edu/ws/index.php?pid=59321 (accessed April 10, 2007).
418. VHA (Veterans Health Administration). 2006. Under Secretary for Health Information Letter: Potential health effects among veterans involved in military chemical warfare agent experiments conducted from 1955 to 1975. Information letter 10-2006-010. Washington, DC: Department of Veterans Affairs. http://www1.va.gov/environagents/docs/USHInfoLetterIL10- 2006-010.pdf (accessed March 7, 2007).
419. IOM (Institution of Medicine). 1993. Veterans at risk: The health effects of mustard gas and lewisite. Washington, DC: National Academy Press.
420. IOM. 1994. Veterans and Agent Orange: Health effects of herbicides used in Vietnam. Washington, DC: National Academy Press.
421. IOM. 1996. Veterans and Agent Orange: Update 199 6. Washington, DC: National Academy Press.
422. IOM. 1999. Veterans and Agent Orange: Update 1998. Washington, DC: National Academy Press.
423. IOM. 2000. Gulf War and health, volume 1: Depleted uranium, pyridostigmine bromide, sarin, vaccines. Washington, DC: National Academy Press.
424. IOM. 2000. Veterans and Agent Orange: Herbicide/dioxin exposure and type 2 diabetes. Washington, DC: National Academy Press.
425. IOM. 2001. Veterans and Agent Orange: Update 2000. Washington, DC: National Academy Press.
426. IOM. 2003. Gulf War and health, volume 2: Insecticides and solvents. Washington, DC: The National Academies Press.
427. IOM. 2003. Veterans and Agent Orange: Update 2002. Washington, DC: The National Academies Press.
428. IOM. 2005. Gulf War and health, volume 3: Fuels, combustion products, propellants. Washington, DC: The National Academies Press.
429. IOM. 2005. Veterans and Agent Orange: Update 2004. Washington, DC: The National Academies Press.
430. IOM. 2006. Gulf War and health, volume 4: Health effects of serving in the Gulf War. Washington, DC: The National Academies Press.
431. IOM. 2007. Gulf War and health, volume 5: Infectious diseases. Washington, DC: The National Academies Press.
432. IOM. 1993. Veterans at risk: The health effects of mustard gas and lewisite. Washington, DC: National Academy Press.
433. IOM. 1994. Veterans and Agent Orange: Health effects of herbicides used in Vietnam. Washington, DC: National Academy Press.
434. IOM. 1996. Veterans and Agent Orange: Update 199 6. Washington, DC: National Academy Press.
435. IOM. 1999. Veterans and Agent Orange: Update 1998. Washington, DC: National Academy Press.
436. IOM. 2000. Gulf War and health, volume 1: Depleted uranium, pyridostigmine bromide, sarin, vaccines. Washington, DC: National Academy Press.
437. IOM. 2000. Veterans and Agent Orange: Herbicide/dioxin exposure and type 2 diabetes. Washington, DC: National Academy Press.
438. IOM. 2001. Veterans and Agent Orange: Update 2000. Washington, DC: National Academy Press.
439. IOM. 2003. Gulf War and health, volume 2: Insecticides and solvents. Washington, DC: The National Academies Press.
440. IOM. 2003. Veterans and Agent Orange: Update 2002. Washington, DC: The National Academies Press.
441. IOM. 2005. Gulf War and health, volume 3: Fuels, combustion products, propellants. Washington, DC: The National Academies Press.
442. IOM. 2005. Veterans and Agent Orange: Update 2004. Washington, DC: The National Academies Press.
443. IOM. 2006. Gulf War and health, volume 4: Health effects of serving in the Gulf War. Washington, DC: The National Academies Press.
444. IOM. 2007. Gulf War and health, volume 5: Infectious diseases. Washington, DC: The National Academies Press.
445. NRC (National Research Council). 1998. Research priorities for airborne particulate matter: I. Immediate priorities and a long-range research portfolio. Washington, DC: National Academy Press.